Merck, Eisai to discontinue late-stage study for skin cancer Reuters Apr 10, 2023 Improvement in overall survival was one of the study's dual main goals, according to Merck and Eisai
University of East Anglia researchers make a breakthrough for ‘next gen’ cancer treatment EP News Bureau Feb 17, 2023 The treatment would work by switching on LED lights embedded close to a tumour, which would then activate biotherapeutic drugs
Wellcome Trust/DBT India Alliance confers award to promote research on pigmentary disorders EP News Bureau Feb 28, 2020 Dr Rajender K Motiani, Assistant Professor at Faridabad-based Regional Centre for Biotechnology receives Rs 3.6 crore grant to…